Mangaluru: Youth hacked to death at Katipalla in broad daylight

Bengaluru, May 27: Amidst helpless calls for learning to live with coronavirus and make a new beginning, the government of Karnataka is considering to reopen schools in the state from July 1.

Primary Education Minister S Suresh Kumar discussed the issue with the officials from the department at a meeting held on Tuesday. 

The expert committee in its report submitted to the Union Ministry for Human Resource Development recommended reopening of schools on July 1. The state department of primary and secondary education also discussed the issue. 

However, no decision has been taken yet and final decision is expected to out in a day or two. A source said that since the timetable for SSLC examination had been published and the lockdown was expected to be lifted after May 31, it had been planned to reopen the schools on July 1.

Following the recent representation by several academicians and social activists urging to cancel SSLC exams, the primary education minister met chief minister and briefed him about preparations for the safe conduct of exams.

“As of now there will not be any changes in SSLC exam schedule. We have reviewed the situation and preparations are underway for ensuring safety of children,” the source added. 

The report submitted by Nimhans about online education is yet to reach the secretariat.

Bengaluru, Feb 20: The poultry industry is facing losses amid rumours of the discovery of a chicken infected with coronavirus in Bengaluru.

DK Kantharaju, president, Karnataka Cooperative Poultry Federation said, "Karnataka is facing losses of Rs 60 to 65 crores. The consumption percentage has also decreased by 30-35 per cent".

Atiq, a meat seller, said, "Because of coronavirus people are scared. But I want to say that chicken is safe to consume here. All this fear is caused due to fake news on social media."

Another person Abdul Hafeez said, "Chicken and coronavirus are not related. People are scared because of what is being spread on social media. The business has definitely gone down due to fear of coronavirus."

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.